# Main Street Capital CORP: financial statements, quarterly

MAIN · NYSE · CIK 1396440 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/main.md) · [Financials](/companies/main/financials.md) · [Filings](/companies/main/filings.md) · [Insiders](/companies/main/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/main/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [26.4](/filings/0001396440-23-000140.md) | [24.4 d](/filings/0001396440-24-000055.md) | [26.8](/filings/0001396440-24-000082.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [6.6](/filings/0001396440-24-000236.md) | [(23.4) d](/filings/0001396440-26-000016.md) | [0.0](/filings/0001396440-25-000102.md) | [0.0](/filings/0001396440-25-000102.md) | [0.0](/filings/0001396440-25-000184.md) | [0.0 d](/filings/0001396440-26-000016.md) | [0.0](/filings/0001396440-25-000102.md) | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [103](/filings/0001396440-24-000236.md) | [139 d](/filings/0001396440-26-000016.md) | [107](/filings/0001396440-25-000184.md) | [103](/filings/0001396440-25-000184.md) | [124](/filings/0001396440-25-000184.md) | [174 d](/filings/0001396440-26-000016.md) | [116](/filings/0001396440-26-000094.md) | [123](/filings/0001396440-26-000094.md) | [124](/filings/0001396440-25-000184.md) | [131 d](/filings/0001396440-26-000016.md) | [49.0](/filings/0001396440-26-000094.md) | [148](/filings/0001396440-26-000094.md) |
| Diluted EPS | $ per share | [0.99](/filings/0001396440-24-000236.md) | not reported | [1.02](/filings/0001396440-25-000102.md) | [0.97](/filings/0001396440-25-000102.md) | [0.96](/filings/0001396440-25-000184.md) | not reported | [0.97](/filings/0001396440-26-000073.md) | [0.99](/filings/0001396440-25-000102.md) | [0.97](/filings/0001396440-25-000184.md) | not reported | [0.93](/filings/0001396440-26-000073.md) | not reported |
| Basic EPS | $ per share | [0.99](/filings/0001396440-24-000236.md) | not reported | [1.02](/filings/0001396440-25-000102.md) | [0.97](/filings/0001396440-25-000102.md) | [0.96](/filings/0001396440-25-000184.md) | not reported | [0.97](/filings/0001396440-26-000073.md) | [0.99](/filings/0001396440-25-000102.md) | [0.97](/filings/0001396440-25-000184.md) | not reported | [0.93](/filings/0001396440-26-000073.md) | not reported |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [77.0](/filings/0001396440-23-000140.md) | [60.1](/filings/0001396440-25-000018.md) | [115](/filings/0001396440-24-000082.md) | [30.5](/filings/0001396440-24-000154.md) | [84.4](/filings/0001396440-24-000236.md) | [78.3](/filings/0001396440-26-000016.md) | [109](/filings/0001396440-25-000068.md) | [87.0](/filings/0001396440-25-000102.md) | [30.6](/filings/0001396440-25-000184.md) | [42.0](/filings/0001396440-26-000094.md) | [20.8](/filings/0001396440-26-000073.md) | [58.3](/filings/0001396440-26-000094.md) |
| Total assets | $m | [4,468](/filings/0001396440-23-000140.md) | [4,444](/filings/0001396440-25-000018.md) | [4,759](/filings/0001396440-24-000082.md) | [4,957](/filings/0001396440-24-000154.md) | [5,095](/filings/0001396440-24-000236.md) | [5,121](/filings/0001396440-26-000016.md) | [5,273](/filings/0001396440-25-000068.md) | [5,288](/filings/0001396440-25-000102.md) | [5,283](/filings/0001396440-25-000184.md) | [5,682](/filings/0001396440-26-000094.md) | [5,828](/filings/0001396440-26-000073.md) | [5,941](/filings/0001396440-26-000094.md) |
| Total liabilities | $m | [2,097](/filings/0001396440-23-000140.md) | [1,966](/filings/0001396440-25-000018.md) | [2,243](/filings/0001396440-24-000082.md) | [2,378](/filings/0001396440-24-000154.md) | [2,403](/filings/0001396440-24-000236.md) | [2,324](/filings/0001396440-26-000016.md) | [2,433](/filings/0001396440-25-000068.md) | [2,404](/filings/0001396440-25-000102.md) | [2,348](/filings/0001396440-25-000184.md) | [2,688](/filings/0001396440-26-000094.md) | [2,735](/filings/0001396440-26-000073.md) | [2,775](/filings/0001396440-26-000094.md) |
| Long-term debt | $m | [1,935](/filings/0001396440-23-000140.md) | [1,802](/filings/0001396440-25-000018.md) | [2,048](/filings/0001396440-24-000082.md) | [2,198](/filings/0001396440-24-000154.md) | [2,199](/filings/0001396440-24-000236.md) | [2,122](/filings/0001396440-26-000016.md) | [2,253](/filings/0001396440-25-000068.md) | [2,217](/filings/0001396440-25-000102.md) | [2,150](/filings/0001396440-25-000184.md) | [2,458](/filings/0001396440-26-000094.md) | [2,530](/filings/0001396440-26-000073.md) | [2,534](/filings/0001396440-26-000094.md) |
| Shareholders' equity | $m | [2,371](/filings/0001396440-24-000236.md) | [2,477](/filings/0001396440-26-000016.md) | [2,516](/filings/0001396440-25-000184.md) | [2,579](/filings/0001396440-25-000184.md) | [2,692](/filings/0001396440-25-000184.md) | [2,798](/filings/0001396440-26-000094.md) | [2,840](/filings/0001396440-26-000094.md) | [2,884](/filings/0001396440-26-000094.md) | [2,935](/filings/0001396440-25-000184.md) | [2,994](/filings/0001396440-26-000094.md) | [3,094](/filings/0001396440-26-000094.md) | [3,167](/filings/0001396440-26-000094.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [84.0 d](/filings/0001396440-24-000236.md) | [154 d](/filings/0001396440-26-000016.md) | [(118)](/filings/0001396440-25-000068.md) | [(186) d](/filings/0001396440-25-000102.md) | [72.4 d](/filings/0001396440-25-000184.md) | [145 d](/filings/0001396440-26-000016.md) | [(20.4)](/filings/0001396440-26-000073.md) | [103 d](/filings/0001396440-26-000094.md) | [90.6 d](/filings/0001396440-25-000184.md) | [(218) d](/filings/0001396440-26-000016.md) | [(139)](/filings/0001396440-26-000073.md) | [117 d](/filings/0001396440-26-000094.md) |
| Dividends paid | $m | [57.0](/filings/0001396440-23-000140.md) | [138 d](/filings/0001396440-26-000016.md) | [86.8](/filings/0001396440-25-000068.md) | [88.0](/filings/0001396440-25-000102.md) | [90.6](/filings/0001396440-25-000184.md) | [91.5 d](/filings/0001396440-26-000016.md) | [93.1](/filings/0001396440-26-000073.md) | [93.7](/filings/0001396440-26-000094.md) | [95.5](/filings/0001396440-25-000184.md) | [95.7 d](/filings/0001396440-26-000016.md) | [98.1](/filings/0001396440-26-000073.md) | [101](/filings/0001396440-26-000094.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [75.0](/filings/0001396440-23-000140.md) | [79.6](/filings/0001396440-24-000082.md) | [80.8](/filings/0001396440-24-000154.md) | [82.9](/filings/0001396440-24-000236.md) | [85.1](/filings/0001396440-25-000068.md) | [86.2](/filings/0001396440-25-000102.md) | [87.5](/filings/0001396440-25-000184.md) | [88.7](/filings/0001396440-26-000073.md) | [89.3](/filings/0001396440-26-000094.md) | [89.6](/filings/0001396440-25-000184.md) | [90.7](/filings/0001396440-26-000073.md) | [93.3](/filings/0001396440-26-000094.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 93,508,461 at 2026-08-06, from the cover of the [10-Q filed 2026-08-07](/filings/0001396440-26-000094.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.